TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
- 18 July 2005
- Vol. 23 (45) , 5263-5270
- https://doi.org/10.1016/j.vaccine.2005.06.024
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Controlling the Toll road to dendritic cell polarizationJournal of Leukocyte Biology, 2004
- The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamilyEuropean Journal of Immunology, 2003
- Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartmentsEuropean Journal of Immunology, 2002
- Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12European Journal of Immunology, 2001
- Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODNCellular Immunology, 2000
- Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shockEuropean Journal of Immunology, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigenEuropean Journal of Immunology, 1994
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993